Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab.
J Allergy Clin Immunol
; 149(4): 1329-1339, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34857395
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prurigo
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2022
Type:
Article